The Deloitte Center for Health Solutions asked 50 clinical leaders at health systems, hospitals and ambulatory surgery centers about their biggest concerns around COVID-19’s effect on deferred services. The survey was conducted during the first two weeks of May.
Deloitte found clinical leaders estimated that their elective procedure volume in April represented only 16 percent of what they normally see, and returning to pre-COVID-19 volumes could take between two and six months.
While 82 percent of respondents said the possibility of an outbreak or second wave topped their list of worries around resuming elective procedures, 54 percent said low patient demand also was a big concern. Half were worried about medications, equipment or testing.
Read the full survey results here.
More articles on leadership:
The ‘better than normal’ future: Hartford HealthCare CEO aims to emerge from COVID-19 more innovative than before
NewYork-Presbyterian CXO Rick Evans: Leading through a spring like no other
COVID-19 challenges healthcare’s status quo: 3 things to know
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
